| Tremelimumab With Chemoembolization or Ablation for Liver Cancer (NCT01853618) | National Cancer Institute (NCI) | 2013-05-02 |
| Preoperative Pain Control in Liver Surgery Patients (NCT01923948) | Eastern Hepatobiliary Surgery Hospital | 2013-05-01 |
| Comparison Between Unilateral Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction to Use a LCD Stent (NCT01875549) | Kwang Hyuck Lee | 2013-05-01 |
| Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib (NCT01840592) | Memorial Sloan Kettering Cancer Center | 2013-04-01 |
| Influence of Probiotics Administration Before Liver Resection in Liver Disease (NCT02021253) | University Hospital, Rouen | 2013-04-01 |
| Resminostat (YHI-1001) in Combination With Sorafenib in Asian Patients With Advanced Hepatocellular Carcinoma (HCC) (NCT02400788) | Yakult Honsha Co., LTD | 2013-04-01 |
| A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular Carcinoma (NCT02004210) | Seoul National University Hospital | 2013-04-01 |
| Combined Chemoembolization and Systemic Hyperthermia for Unresectable Hepatocellular Carcinoma (NCT01817205) | Chinese University of Hong Kong | 2013-03-01 |
| Multicenter RCT of ADV-TK Gene Therapy Improving the Outcome of Liver Transplantation for Advanced HCC (NCT03313596) | Huazhong University of Science and Technology | 2013-03-01 |
| P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. (NCT01834963) | Kansai Hepatobiliary Oncology Group | 2013-03-01 |
| Laparoscope Anatomical and Aon-anatomical Hepatectomy (NCT02009176) | Shuguo Zheng, MD | 2013-03-01 |
| CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma (NCT04715321) | Sun Yat-sen University | 2013-02-15 |
| Effect of Vascular Inflow Occlusion in Open Liver Resection for Hepatocellular Carcinoma (NCT01759901) | Chinese University of Hong Kong | 2013-01-01 |
| Dose Escalation Trial of Tefinostat for Cancer Associated Inflamation in Hepatocellular Carcinoma (HCC) (NCT02759601) | Queen Mary University of London | 2013-01-01 |
| Postoperative Adjuvant TACE Treatment in CK18 Positive Patients (NCT02724345) | Eastern Hepatobiliary Surgery Hospital | 2013-01-01 |
| TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma (NCT01869088) | Sun Yat-sen University | 2013-01-01 |
| Boramae Hospital Liver Cirrhosis Patient Cohort Study (NCT01943318) | Seoul National University Boramae Hospital | 2013-01-01 |
| Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy (NCT01755767) | Daiichi Sankyo | 2012-12-27 |
| Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer (NCT01631552) | Gilead Sciences | 2012-12-17 |
| Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Liver Cancer Receiving Transarterial Chemoembolization With Drug Eluting Beads (NCT03045497) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-12-12 |
| Microparticle Enhanced Cytotoxic Transarterial Embolization Therapy in Hepatocellular Carcinoma (NCT01798134) | Boston Scientific Corporation | 2012-12-01 |
| Laparoscopic Versus Open Liver Resection in the Treatment of Hepatocellular Carcinoma (NCT01768741) | Sir Run Run Shaw Hospital | 2012-12-01 |
| Laser Ablation for Intermediate and Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus (NCT02724475) | Eastern Hepatobiliary Surgery Hospital | 2012-12-01 |
| SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) (NCT01752933) | Astex Pharmaceuticals, Inc. | 2012-12-01 |
| Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology (NCT02727673) | Eastern Hepatobiliary Surgery Hospital | 2012-12-01 |
| Rg3 in Combination With TACE in Hepatocellular Carcinoma Patients With High Expression of Notch1 (NCT02724358) | Eastern Hepatobiliary Surgery Hospital | 2012-12-01 |
| Standard Treatments of Very-early Stage Hepatocellular Carcinoma (NCT02728193) | Eastern Hepatobiliary Surgery Hospital | 2012-12-01 |
| Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma (NCT02724436) | Eastern Hepatobiliary Surgery Hospital | 2012-12-01 |
| Adjuvant Anti-Recurrence Treatment With Rapamycin on Early-stage HCC (NCT02724332) | Eastern Hepatobiliary Surgery Hospital | 2012-11-01 |
| A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers (NCT02828865) | National Taiwan University Hospital | 2012-11-01 |
| A Phase 1 Study of MM-141 in Patients With Advanced Solid Tumors (NCT01733004) | Merrimack Pharmaceuticals | 2012-11-01 |
| An Immuno-therapy Study to Evaluate the Effectiveness, Safety and Tolerability of Nivolumab or Nivolumab in Combination With Other Agents in Patients With Advanced Liver Cancer (NCT01658878) | Bristol-Myers Squibb | 2012-10-30 |
| Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma (NCT01687673) | University of California, San Francisco | 2012-10-05 |
| Radiofrequency Ablation Assisted Hepatectomy Versus Hepatectomy Alone for Advanced Hepatocellular Carcinoma (NCT01713244) | Southwest Hospital, China | 2012-10-01 |
| Comparing Lipiodol/Ethanol With Drug-eluting Beads (DEB) for Hepatocellular Carcinoma (NCT01489410) | University of Minnesota | 2012-10-01 |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion (NCT01850368) | Korea Cancer Center Hospital | 2012-10-01 |
| The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene (NCT01786980) | Eastern Hepatobiliary Surgery Hospital | 2012-10-01 |
| Response of Hepatic Tumors to Radioembolization (NCT01775280) | University of Zurich | 2012-10-01 |
| VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway (NCT01892072) | First Affiliated Hospital, Sun Yat-Sen University | 2012-10-01 |
| Optimization of Health Expenditure in Liver Surgery (NCT01715402) | Centre Hospitalier Universitaire, Amiens | 2012-09-30 |
| A Multicentre, Open Label, Phase 1 Trial in Japan of the Mitogen Activated Protein Extracellular Signal Regulated Kinase (MEK) Inhibitor Pimasertib Given Orally to Subjects With Solid Tumors as Monotherapy (NCT01668017) | Merck KGaA, Darmstadt, Germany | 2012-09-30 |
| Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma (NCT01872988) | Taichung Veterans General Hospital | 2012-09-01 |
| Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver (NCT01686880) | Jules Bordet Institute | 2012-09-01 |
| Hepatocellular Carcinoma Registry for Turkey (3K Trial) (NCT01473121) | Bayer | 2012-08-13 |
| Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors (NCT01628640) | Mayo Clinic | 2012-08-03 |
| Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy (NCT01668381) | First Affiliated Hospital, Sun Yat-Sen University | 2012-08-01 |
| Transarterial Chemoembolization Prior to Transplantation for Hepatocellular Carcinoma (NCT01676194) | Rennes University Hospital | 2012-08-01 |
| Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression (NCT01681446) | Fudan University | 2012-08-01 |
| Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma (NCT01677468) | Hallym University Medical Center | 2012-08-01 |
| Utility Study of Primovist-MRI on HCC Staging (NCT01764438) | Inha University Hospital | 2012-08-01 |
| Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis (NCT01575574) | Sara Varea | 2012-07-01 |
| Phase II Trial of SOM230 in Patients With Unresectable Hepatocellular Carcinoma (NCT01639352) | Lynn Feun | 2012-07-01 |
| Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma (NCT02585687) | Hospices Civils de Lyon | 2012-07-01 |
| Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery (NCT01690715) | Hospital Sirio-Libanes | 2012-07-01 |
| Hypofractionated Proton Beam Radiotherapy for Hepatocellular Carcinoma (NCT01643824) | National Cancer Center, Korea | 2012-06-07 |
| Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma ≤ 5 cm (NCT01825824) | Korea Cancer Center Hospital | 2012-06-01 |
| Sorafenib VS TACE in HCC Patients With Portal Vein Invasion (NCT01480817) | Seoul National University Hospital | 2012-06-01 |
| Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC) (NCT01643447) | Eastern Hepatobiliary Surgery Hospital | 2012-05-01 |
| Procalcitonin in Hepatocellular Carcinoma (NCT01518829) | Ain Shams University | 2012-04-01 |
| Body Composition Analysis in Patients Undergoing Chemoembolization (NCT01777698) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2012-04-01 |
| Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215) (NCT01521780) | Merck Sharp & Dohme LLC | 2012-04-01 |
| Hepatic Xenetix-CT Perfusion (NCT01639703) | Guerbet | 2012-04-01 |
| Determine the Pharmacokinetics and Safety of Brivanib in Chinese Subjects With Advanced Primary Liver Cancer (Hepatocellular Carcinoma: HCC) (NCT01540461) | Bristol-Myers Squibb | 2012-03-01 |
| Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant (NCT01559844) | Gilead Sciences | 2012-03-01 |
| Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis (NCT03518502) | Korea University | 2012-03-01 |
| Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy (NCT01539681) | Bayer | 2012-02-01 |
| A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) (NCT01801163) | Indiana University | 2012-02-01 |
| Chemoembolization for Hepatocellular Carcinoma (NCT02821533) | Chinese University of Hong Kong | 2012-02-01 |
| Recurrence of Hepatocellular Carcinoma (NCT01520779) | Ain Shams University | 2012-01-01 |
| The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List (NCT01575717) | Andrea Branch | 2012-01-01 |
| Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma (NCT01850667) | Korea Cancer Center Hospital | 2012-01-01 |
| Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient (NCT01858207) | Shi-Ming Lin | 2012-01-01 |
| Neoadjuvant Sorafenib Therapy Prior to Laser Ablation for Hepatocellular Carcinoma (NCT01507064) | Cardarelli Hospital | 2012-01-01 |
| The LC Bead Trial; Transarterial Chemoembolization of Hepatocellular Carcinoma (HCC)With a Drug-eluting Bead (NCT01259024) | Washington University School of Medicine | 2011-12-01 |
| Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis (NCT01357486) | University Hospital, Bordeaux | 2011-11-14 |
| S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) (NCT01533324) | Second Military Medical University | 2011-11-01 |
| Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies: Follow-up Study (NCT02745483) | Seoul National University Hospital | 2011-11-01 |
| Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma (NCT01570166) | Sun Yat-sen University | 2011-11-01 |
| Caphosol in Oral Mucositis Due to Targeted Therapy (NCT01265810) | Impaqtt Foundation | 2011-11-01 |
| Radiofrequency Ablation Versus Liver Resection for Elderly Patients With Hepatocellular Carcinoma (HCC) Within the Milan Criteria (NCT01570075) | Sun Yat-sen University | 2011-11-01 |
| RCT on Adjuvant TACE After Hepatectomy for HCC (NCT01512407) | Chinese University of Hong Kong | 2011-11-01 |
| Radiofrequency Ablation Using Octopus Electrodes for Treatment of Focal Liver Malignancies (NCT02683538) | Seoul National University Hospital | 2011-11-01 |
| A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (NCT01387555) | Jennerex Biotherapeutics | 2011-10-08 |
| Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) (NCT01447667) | Seoul National University Hospital | 2011-10-01 |
| Efficacy of Radiation Therapy and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma (HCC) (NCT01432314) | Asan Medical Center | 2011-10-01 |
| PROLIFICA - West African Treatment Cohort for Hepatitis B (NCT02129829) | Imperial College London | 2011-10-01 |
| Prediction of Liver-related Outcomes After HCV Cure (NCT04460157) | Hospital Universitario de Valme | 2011-10-01 |
| Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of Hepatocellular Carcinoma (HCC) (NCT01381211) | University Hospital, Ghent | 2011-09-01 |
| A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid Tumors (NCT01462903) | Sun Yat-sen University | 2011-09-01 |
| A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection (NCT01402908) | Cellxpert Biotechnology Corp. | 2011-08-01 |
| TACE as an Adjuvant Therapy After Hepatectomy for HCC (NCT01966133) | Jia Fan | 2011-08-01 |
| Carbon Ion Radiotherapy for Hepatocellular Carcinoma (NCT01167374) | University Hospital Heidelberg | 2011-08-01 |
| PLA for HCC and Esophageal ca Serum (NCT01957241) | National Taiwan University Hospital | 2011-08-01 |
| E7050 in Combination With Sorafenib Versus Sorafenib Alone as First Line Therapy in Participants With Hepatocellular Carcinoma (NCT01271504) | Eisai Inc. | 2011-07-19 |
| Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy (NCT01287585) | Polaris Group | 2011-07-01 |
| Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) (NCT01392131) | Clinical Research Organization, Dhaka, Bangladesh | 2011-07-01 |
| Phase I/II Study of OPB-31121 in Patients With Progressive Hepatocellular Carcinoma (NCT01406574) | Otsuka Pharmaceutical Co., Ltd. | 2011-07-01 |
| A Study of Dovitinib Versus Sorafenib in Adult Patients With Hepatocellular Carcinoma (HCC) as a First Line Treatment (NCT01232296) | Novartis Pharmaceuticals | 2011-07-01 |
| Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients (NCT01489566) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2011-07-01 |
| TRC105 for Liver Cancer That Has Not Responded to Sorafenib (NCT01375569) | National Cancer Institute (NCI) | 2011-06-22 |